✦ LIBER ✦

Plasminogen activator system in oral squamous cell carcinoma

✍ Scribed by E.A. Baker; D.J. Leaper; J.P. Hayter; A.J. Dickenson

Book ID: 116316334
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 149 KB
Volume: 45
Category: Article
ISSN: 0266-4356
DOI: 10.1016/j.bjoms.2007.04.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunohistochemical localization of a ur

Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis

✍ S Nozaki; Y Endo; S Kawashiri; K Nakagawa; E Yamamoto; Y Yonemura; T Sasaki 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 391 KB

Prognostic value analysis of urokinase-t

Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study

✍ Roberta Bacchiocchi; Corrado Rubini; Elisa Pierpaoli; Giulia Borghetti; Pasquale 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 436 KB

RNAi targeting urokinase-type plasminoge

RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo

✍ Hao Zhou; Yaling Tang; Xinhua Liang; Xiaoqin Yang; Jing Yang; Guiquan Zhu; Min Z 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 809 KB

## Abstract It has been admitted that urokinase‐type plasminogen activator receptor (u‐PAR) is overexpressed in many human malignant tumors including oral squamous cell carcinoma (OSCC) and plays an important role in a variety of cancer key cellular events as a versatile signaling orchestrator. In

RNA interference targeting urokinase-typ

RNA interference targeting urokinase-type plasminogen activator receptor inhibits tumour growth of oral squamous cell carcinoma in vivo

✍ X. Liang; H. Zhou; Y. Tang; X. Yang; J. Yang; G. Zhu; M. Zheng; C. Zhang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 90 KB

The matrix metalloproteinase system in o

The matrix metalloproteinase system in oral squamous cell carcinoma

✍ E.A. Baker; D.J. Leaper; J.P. Hayter; A.J. Dickenson 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Clinical relevance of urokinase-type pla

Clinical relevance of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in oral squamous cell carcinoma (OSCC)

✍ H.-F. Zeilhofer; K.P. Bock; P. Dettmar; B. Hundsdorfer; K. Ulm; R. Sader; H.-H. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB